VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson’s disease

Valosin-containing human protein (VCP) or p97 performs enzyme functions associated with the maintenance of protein homeostasis and control of protein quality. Disruption of its normal functioning might be associated with the development of Parkinson’s disease (PD). Tissues of mice with toxin-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Alieva, Anelya, Rudenok, Margarita, Filatova, Elena, Karabanov, Alexey, Doronina, Olga, Doronina, Kseniya, Kolacheva, Anna, Ugrumov, Mikhail, Illarioshkin, Sergey, Slominsky, Petr, Shadrina, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972783/
https://www.ncbi.nlm.nih.gov/pubmed/31964996
http://dx.doi.org/10.1038/s41598-020-57938-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972783/
https://www.ncbi.nlm.nih.gov/pubmed/31964996
http://dx.doi.org/10.1038/s41598-020-57938-3

Ejemplares similares